Health status, healthcare, and access in children with long-term medication use and difficulties with emotion,

Yuyin Yang1, Beck L Reyes2, Eufemia Jacob3

  • 1UCLA Department of Psychology, Los Angeles, California, USA.

Insights

Children on long-term medication (LTM) often experience emotional, concentration, and behavioral (ECB) difficulties. Further evaluation is needed to understand and address these co-occurring challenges in pediatric chronic illness care.

Area of Science:

  • Pediatric Health
  • Chronic Illness Management
  • Child Psychology

Background:

  • Children with chronic conditions frequently exhibit emotional, concentration, and behavioral (ECB) difficulties.
  • These ECB challenges are often inadequately recognized and treated.
  • Long-term medication use (LTM) serves as a proxy for chronic illness in children due to diagnostic criteria limitations.

Purpose of the Study:

  • To investigate the prevalence of emotional, concentration, and behavioral (ECB) difficulties in children using long-term medication (LTM).
  • To analyze the characteristics and healthcare access of children experiencing both LTM and ECB challenges.

Main Methods:

  • Utilized data from the 2017 California Health Interview Survey (CHIS).
  • Selected children aged 8-12 years based on parental reports of requiring prescription medicine for a chronic condition and experiencing ECB difficulties.
  • Analyzed demographic data, insurance status, healthcare utilization, and prescription delays.

Main Results:

  • Children with both LTM and ECB difficulties were predominantly Caucasian (56.4%) and male (64.5%).
  • This group frequently had multiple physician visits and received special therapy.
  • Barriers to care included prescription delays and lack of insurance, with a significant portion relying on Medi-Cal/Medicaid.

Conclusions:

  • Children on long-term medication require comprehensive evaluation for co-occurring emotional, concentration, and behavioral difficulties.
  • Future research should explore the health status, healthcare utilization, and access for children with both LTM and ECB challenges.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
403
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
232
Socioemotional Development during Infancy01:30

Socioemotional Development during Infancy

Socio-emotional development in infancy is primarily shaped by early emotional responses and social connections, with temperament playing a central role. Temperament refers to the consistent patterns in an individual's emotional and behavioral responses, observable even in infancy. By examining temperament, researchers can better understand an infant's unique ways of interacting with the world, influencing subsequent personality and socio-emotional growth.
Primary Temperament Types
172
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
108
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
179
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
337